Martingale Asset Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,222
| Closed | -$69.5K | – | 844 |
|
|
2023
Q1 | $69.5K | Sell |
2,222
-3,376
| -60% | -$106K | ﹤0.01% | 811 |
|
|
2022
Q4 | $394K | Buy |
+5,598
| New | +$394K | 0.01% | 667 |
|
|
2021
Q4 | – | Sell |
-2,612
| Closed | -$226K | – | 858 |
|
|
2021
Q3 | $226K | Buy |
+2,612
| New | +$226K | ﹤0.01% | 799 |
|
|
2020
Q4 | – | Sell |
-5,532
| Closed | -$268K | – | 976 |
|
|
2020
Q3 | $268K | Sell |
5,532
-9,570
| -63% | -$464K | ﹤0.01% | 926 |
|
|
2020
Q2 | $783K | Buy |
+15,102
| New | +$783K | 0.01% | 789 |
|